West Pharmaceutical Services Inc. (NYSE:WST) Position Lowered by Portland Hill Asset Management Ltd

Portland Hill Asset Management Ltd decreased its holdings in West Pharmaceutical Services Inc. (NYSE:WST) by 5.9% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 48,824 shares of the medical instruments supplier’s stock after selling 3,062 shares during the quarter. West Pharmaceutical Services makes up about 2.6% of Portland Hill Asset Management Ltd’s investment portfolio, making the stock its 13th largest position. Portland Hill Asset Management Ltd owned approximately 0.07% of West Pharmaceutical Services worth $5,991,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Integrated Investment Consultants LLC bought a new stake in shares of West Pharmaceutical Services in the second quarter valued at about $155,000. First Allied Advisory Services Inc. bought a new stake in West Pharmaceutical Services during the second quarter worth about $200,000. Alps Advisors Inc. bought a new stake in West Pharmaceutical Services during the second quarter worth about $206,000. Grandfield & Dodd LLC bought a new stake in West Pharmaceutical Services during the second quarter worth about $207,000. Finally, Wetherby Asset Management Inc. bought a new stake in West Pharmaceutical Services during the second quarter worth about $223,000. Hedge funds and other institutional investors own 92.62% of the company’s stock.

Several analysts have issued reports on the company. Zacks Investment Research upgraded West Pharmaceutical Services from a “hold” rating to a “buy” rating and set a $123.00 price objective on the stock in a research note on Tuesday, July 31st. ValuEngine upgraded West Pharmaceutical Services from a “hold” rating to a “buy” rating in a research note on Wednesday, October 17th.

Shares of West Pharmaceutical Services stock traded up $0.06 on Thursday, hitting $105.23. The stock had a trading volume of 224,551 shares, compared to its average volume of 387,267. The company has a market capitalization of $7.79 billion, a price-to-earnings ratio of 37.85, a PEG ratio of 3.94 and a beta of 1.19. West Pharmaceutical Services Inc. has a twelve month low of $82.74 and a twelve month high of $125.09. The company has a current ratio of 2.94, a quick ratio of 2.23 and a debt-to-equity ratio of 0.15.

West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings results on Thursday, October 25th. The medical instruments supplier reported $0.76 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.70 by $0.06. The business had revenue of $431.70 million for the quarter, compared to the consensus estimate of $427.55 million. West Pharmaceutical Services had a return on equity of 15.78% and a net margin of 9.06%. As a group, equities research analysts predict that West Pharmaceutical Services Inc. will post 2.83 earnings per share for the current fiscal year.

WARNING: “West Pharmaceutical Services Inc. (NYSE:WST) Position Lowered by Portland Hill Asset Management Ltd” was reported by Enterprise Leader and is the property of of Enterprise Leader. If you are accessing this piece on another site, it was stolen and republished in violation of United States and international copyright law. The legal version of this piece can be accessed at https://theenterpriseleader.com/2018/11/22/west-pharmaceutical-services-inc-wst-shares-sold-by-portland-hill-asset-management-ltd.html.

West Pharmaceutical Services Profile

West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.

Featured Story: What is a capital gain?

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply